EconPapers    
Economics at your fingertips  
 

Therapy Optimization in Population Dynamics Models

Andrzej Świerniak, Marek Kimmel, Jaroslaw Smieja, Krzysztof Puszynski and Krzysztof Psiuk-Maksymowicz
Additional contact information
Andrzej Świerniak: Silesian University of Technology, Institute of Automatic Control
Marek Kimmel: Silesian University of Technology, Institute of Automatic Control
Jaroslaw Smieja: Silesian University of Technology, Institute of Automatic Control
Krzysztof Puszynski: Silesian University of Technology, Institute of Automatic Control
Krzysztof Psiuk-Maksymowicz: Silesian University of Technology, Institute of Automatic Control

Chapter Chapter 3 in System Engineering Approach to Planning Anticancer Therapies, 2016, pp 55-83 from Springer

Abstract: Abstract Cell subpopulations dealt with in the preceding chapter were the result of compartmentalizing the model. In this chapter we focus on growth of cancer cells and the associated vascular system and interactions with the immune system. Therefore, though the variables will still describe the amount of cells of different type, there will be no flux from one type to another. We start with introduction of standard models of population dynamics, with exponential, Gompertzian, and logistic growth. The difference between stochastic and deterministic approach to model population size is explained, a point often misinterpreted in various sources. Then, the angiogenic aspects of cancer growth are discussed, followed by several models of cancer growth including vascularization. Consequently, the problem of optimization of antiangiogenic and combined therapies is analyzed. Finally, models of gene and immunotherapy in cancer treatments are briefly reviewed. In addition to discussion of optimal treatment protocols, the focus of this chapter is on the formal, system engineering-based analysis of dynamical properties System engineering of systems under investigation, such as stability and controllability.

Keywords: Equilibrium Point; Vascular Network; Chimeric Antigen Receptor; Antiangiogenic Therapy; Antiangiogenic Agent (search for similar items in EconPapers)
Date: 2016
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-28095-0_3

Ordering information: This item can be ordered from
http://www.springer.com/9783319280950

DOI: 10.1007/978-3-319-28095-0_3

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2026-05-12
Handle: RePEc:spr:sprchp:978-3-319-28095-0_3